SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹1,321 Cr | ₹1,010 Cr | ₹834 Cr | ₹378 Cr | ₹378 Cr |
Sales | ₹1,254 Cr | ₹949 Cr | ₹774 Cr | ₹344 Cr | ₹344 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹54 Cr | ₹46 Cr | ₹44 Cr | ₹25 Cr | ₹25 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹13 Cr | ₹14 Cr | ₹17 Cr | ₹8.26 Cr | ₹8.26 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹1,320 Cr | ₹1,010 Cr | ₹834 Cr | ₹378 Cr | ₹378 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-60 Cr | ₹-8.37 Cr | ₹-11 Cr | ₹-21 Cr | ₹-21 Cr |
Raw Material Consumed | ₹454 Cr | ₹306 Cr | ₹236 Cr | ₹123 Cr | ₹123 Cr |
Opening Raw Materials | ₹51 Cr | ₹35 Cr | ₹30 Cr | - | - |
Purchases Raw Materials | ₹475 Cr | ₹323 Cr | ₹241 Cr | ₹153 Cr | ₹153 Cr |
Closing Raw Materials | ₹72 Cr | ₹51 Cr | ₹35 Cr | ₹30 Cr | ₹30 Cr |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹60 Cr | ₹44 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr |
Electricity & Power | ₹60 Cr | ₹44 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹100 Cr | ₹76 Cr | ₹65 Cr | ₹30 Cr | ₹30 Cr |
Salaries, Wages & Bonus | ₹91 Cr | ₹68 Cr | ₹58 Cr | ₹26 Cr | ₹26 Cr |
Contributions to EPF & Pension Funds | ₹5.21 Cr | ₹4.18 Cr | ₹3.35 Cr | ₹2.01 Cr | ₹2.01 Cr |
Workmen and Staff Welfare Expenses | ₹2.52 Cr | ₹2.42 Cr | ₹2.57 Cr | ₹1.12 Cr | ₹1.12 Cr |
Other Employees Cost | ₹2.21 Cr | ₹1.86 Cr | ₹1.52 Cr | ₹0.83 Cr | ₹0.83 Cr |
Other Manufacturing Expenses | ₹129 Cr | ₹105 Cr | ₹84 Cr | ₹35 Cr | ₹35 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹22 Cr | ₹20 Cr | ₹15 Cr | ₹12 Cr | ₹12 Cr |
Packing Material Consumed | ₹5.05 Cr | ₹4.38 Cr | ₹3.87 Cr | ₹1.74 Cr | ₹1.74 Cr |
Other Mfg Exp | ₹102 Cr | ₹81 Cr | ₹65 Cr | ₹22 Cr | ₹22 Cr |
General and Administration Expenses | ₹29 Cr | ₹28 Cr | ₹26 Cr | ₹13 Cr | ₹13 Cr |
Rent , Rates & Taxes | ₹0.33 Cr | ₹1.28 Cr | ₹2.51 Cr | ₹0.67 Cr | ₹0.67 Cr |
Insurance | ₹7.11 Cr | ₹7.23 Cr | ₹5.99 Cr | ₹1.61 Cr | ₹1.61 Cr |
Printing and stationery | ₹0.36 Cr | ₹0.36 Cr | ₹0.44 Cr | ₹0.17 Cr | ₹0.17 Cr |
Professional and legal fees | ₹4.09 Cr | ₹4.38 Cr | ₹2.53 Cr | ₹1.84 Cr | ₹1.84 Cr |
Traveling and conveyance | ₹6.87 Cr | ₹6.40 Cr | ₹6.18 Cr | ₹3.20 Cr | ₹3.20 Cr |
Other Administration | ₹10 Cr | ₹8.08 Cr | ₹8.33 Cr | ₹5.13 Cr | ₹5.13 Cr |
Selling and Distribution Expenses | ₹20 Cr | ₹11 Cr | ₹9.43 Cr | ₹6.72 Cr | ₹6.72 Cr |
Advertisement & Sales Promotion | ₹1.88 Cr | ₹1.84 Cr | ₹3.60 Cr | ₹3.91 Cr | ₹3.91 Cr |
Sales Commissions & Incentives | ₹1.59 Cr | ₹1.62 Cr | ₹2.04 Cr | ₹1.02 Cr | ₹1.02 Cr |
Freight and Forwarding | ₹16 Cr | ₹7.07 Cr | ₹3.79 Cr | ₹1.78 Cr | ₹1.78 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹6.37 Cr | ₹5.16 Cr | ₹1.08 Cr | ₹2.69 Cr | ₹2.69 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | ₹0.20 Cr | - | ₹0.02 Cr | - | - |
Losson foreign exchange fluctuations | - | - | - | ₹2.69 Cr | ₹2.69 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹6.17 Cr | ₹5.16 Cr | ₹1.06 Cr | - | - |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹739 Cr | ₹567 Cr | ₹449 Cr | ₹206 Cr | ₹206 Cr |
Operating Profit (Excl OI) | ₹582 Cr | ₹443 Cr | ₹385 Cr | ₹172 Cr | ₹172 Cr |
Other Income | ₹92 Cr | ₹14 Cr | ₹18 Cr | ₹0.60 Cr | ₹0.60 Cr |
Interest Received | ₹0.07 Cr | ₹0.27 Cr | ₹0.36 Cr | ₹0.20 Cr | ₹0.20 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.00 Cr | ₹0.03 Cr | ₹0.08 Cr | - | - |
Profits on sale of Investments | ₹74 Cr | ₹3.33 Cr | ₹6.23 Cr | ₹0.16 Cr | ₹0.16 Cr |
Provision Written Back | ₹0.37 Cr | - | ₹0.15 Cr | ₹0.24 Cr | ₹0.24 Cr |
Foreign Exchange Gains | ₹16 Cr | ₹9.56 Cr | ₹11 Cr | - | - |
Others | ₹1.10 Cr | ₹1.05 Cr | ₹0.26 Cr | - | - |
Operating Profit | ₹674 Cr | ₹457 Cr | ₹403 Cr | ₹172 Cr | ₹172 Cr |
Interest | ₹8.53 Cr | ₹12 Cr | ₹23 Cr | ₹2.79 Cr | ₹2.79 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹4.80 Cr | ₹1.70 Cr | ₹3.91 Cr | ₹0.79 Cr | ₹0.79 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹2.30 Cr | ₹2.52 Cr | ₹3.15 Cr | ₹1.07 Cr | ₹1.07 Cr |
Other Interest | ₹1.43 Cr | ₹7.44 Cr | ₹16 Cr | ₹0.93 Cr | ₹0.93 Cr |
PBDT | ₹666 Cr | ₹446 Cr | ₹380 Cr | ₹169 Cr | ₹169 Cr |
Depreciation | ₹39 Cr | ₹32 Cr | ₹24 Cr | ₹11 Cr | ₹11 Cr |
Profit Before Taxation & Exceptional Items | ₹626 Cr | ₹414 Cr | ₹356 Cr | ₹158 Cr | ₹158 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹668 Cr | ₹414 Cr | ₹356 Cr | ₹158 Cr | ₹158 Cr |
Provision for Tax | ₹214 Cr | ₹105 Cr | ₹88 Cr | ₹49 Cr | ₹49 Cr |
Current Income Tax | ₹190 Cr | ₹102 Cr | ₹89 Cr | ₹33 Cr | ₹33 Cr |
Deferred Tax | ₹23 Cr | ₹3.62 Cr | ₹-1.30 Cr | ₹15 Cr | ₹15 Cr |
Other taxes | - | ₹0.18 Cr | - | - | - |
Profit After Tax | ₹454 Cr | ₹309 Cr | ₹269 Cr | ₹109 Cr | ₹109 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | ₹54 Cr | ₹48 Cr | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹454 Cr | ₹362 Cr | ₹317 Cr | ₹109 Cr | ₹109 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹936 Cr | ₹615 Cr | ₹391 Cr | - | - |
Appropriations | ₹1,390 Cr | ₹978 Cr | ₹708 Cr | ₹109 Cr | ₹109 Cr |
General Reserves | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | ₹13 Cr | - | - |
Other Appropriation | ₹26 Cr | ₹0.84 Cr | ₹0.82 Cr | ₹-297 Cr | ₹-297 Cr |
Equity Dividend % | ₹500.00 | ₹200.00 | ₹500.00 | - | - |
Earnings Per Share | ₹17.83 | ₹14.23 | ₹24.91 | - | - |
Adjusted EPS | ₹17.83 | ₹14.23 | ₹12.45 | - | - |
Compare Income Statement of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,750.1 Cr | 3.2% | 1.4% | 36.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 3.2% |
1.4% |
36.9% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses